BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9391668)

  • 21. Salt-load electrocochleography.
    Gamble BA; Meyerhoff WL; Shoup AG; Schwade ND
    Am J Otol; 1999 May; 20(3):325-30. PubMed ID: 10337972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cervicogenic otoocular syndrome: a suspected forerunner of Ménière's disease.
    Franz B; Altidis P; Altidis B; Collis-Brown G
    Int Tinnitus J; 1999; 5(2):125-30. PubMed ID: 10753431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summating potential-action potential waveform amplitude and width in the diagnosis of Menière's disease.
    Ikino CM; de Almeida ER
    Laryngoscope; 2006 Oct; 116(10):1766-9. PubMed ID: 17003737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ménière's Disease Index: an objective correlate of Ménière's disease, based on audiometric and electrocochleographic data.
    Claes GM; De Valck CF; Van de Heyning P; Wuyts FL
    Otol Neurotol; 2011 Jul; 32(5):887-92. PubMed ID: 21512426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of two methods of using transtympanic electrocochleography for the diagnosis of Meniere's disease: click summating potential/action potential ratio measurements and tone burst summating potential measurements.
    Gibson WP
    Acta Otolaryngol Suppl; 2009 Feb; (560):38-42. PubMed ID: 19221905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up.
    Densert B; Sass K
    Acta Otolaryngol; 2001 Jul; 121(5):616-21. PubMed ID: 11583396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress electrocochleography.
    Franz B; Altidis P; Altidis B
    Int Tinnitus J; 1999; 5(2):113-20. PubMed ID: 10753429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential role of joint injury and eustachian tube dysfunction in the genesis of secondary Ménière's disease.
    Franz B; Anderson C
    Int Tinnitus J; 2007; 13(2):132-7. PubMed ID: 18229792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
    Kitahara T; Kubo T; Okumura S; Kitahara M
    Laryngoscope; 2008 May; 118(5):854-61. PubMed ID: 18520184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ozone therapy and pressure-pulse therapy in Ménière's disease.
    Pawlak-Osińska K; Kaźmierczak H; Kaźmierczak W; Szpoper M
    Int Tinnitus J; 2004; 10(1):54-7. PubMed ID: 15379351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy.
    Diaz RC; LaRouere MJ; Bojrab DI; Zappia JJ; Sargent EW; Shaia WT
    Otol Neurotol; 2007 Jan; 28(1):74-86. PubMed ID: 16985479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT; Parnes LS
    Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral electrocochleographic findings in unilateral Menière's disease.
    Moffat DA; Baguley DM; Harries ML; Atlas M; Lynch CA
    Otolaryngol Head Neck Surg; 1992 Sep; 107(3):370-3. PubMed ID: 1408220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear.
    Conlon BJ; Gibson WP
    Laryngoscope; 1999 Nov; 109(11):1800-2. PubMed ID: 10569410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.